Sleep Specialists announced the development the Zzoma Plus positional sensor, featuring patient adherence tracking and enhanced clinical efficacy data collection, at SLEEP 2024.


Summary: At SLEEP 2024 in Houston, Sleep Specialists introduced Zzoma Plus, an upgraded version of its FDA-cleared Zzoma positional therapy device currently in development. The new device introduces patient adherence tracking and enhanced clinical efficacy data collection, emphasizing a less invasive design. Alongside the Zzoma Plus, Sleep Specialists is initiating a clinical trial to compare the effectiveness of Zzoma positional therapy against CPAP therapy for cardiovascular dysfunction in sleep apnea patients. Additionally, the company has partnered with SleepScore to provide a companion app for patients and has established a new subsidiary focused on value-based healthcare solutions.

Key Takeaways:

  • Sleep Specialists gave a first look at Zzoma Plus, an advanced version of its existing positional therapy device, at SLEEP 2024. This new device, currently in development, includes features for patient adherence tracking and enhanced clinical efficacy data collection, designed to be less invasive.
  • The company announced a clinical trial comparing the efficacy of Zzoma positional therapy to traditional CPAP therapy in addressing cardiovascular dysfunction in sleep apnea patients.
  • Sleep Specialists has partnered with SleepScore to offer a clinically validated companion app alongside Zzoma therapy. This collaboration aims to help patients track their progress, stay motivated, and improve their overall sleep health through data-driven insights and enhanced patient engagement.

Sleep Specialists, owner of the Zzoma positional therapy device, unveiled the Zzoma Plus next-generation positional and adherence sensor, a clinical trial comparing Zzoma with traditional CPAP therapy for cardiovascular risk, and a new subsidiary dedicated to value-based healthcare solutions at SLEEP 2024 in Houston.

Sleep Specialists’ flagship product, Zzoma, is a clinically proven, US Food and Drug Administration (FDA)-cleared positional therapy device for positional obstructive sleep apnea. Building upon the original device, Zzoma Plus introduces patient adherence tracking and enhanced clinical efficacy data collection. The next-generation device is designed to be less invasive via advanced product design and digital technology.

Zzoma Plus is currently under development and has not yet received FDA clearance.

Clinical Trial and New Partnership

Additionally, Sleep Specialists is launching a clinical trial comparing the use of Zzoma positional therapy to CPAP on cardiovascular dysfunction in sleep apnea. This research underscores Zzoma’s commitment to advancing sleep solutions and offering physicians and patients data-driven treatment choices.

Sleep Specialists also announced a partnership with SleepScore to offer the clinically validated SleepScore companion app alongside Zzoma therapy. This system aims to empower patients to track their progress, stay motivated, and experience the benefits of improved sleep health, according to a release from the company.

Photo 37190779 © Wavebreak Media Ltd | Dreamstime.com